Main Menu

resTORbio, Inc.



Attention investors who purchased shares of resTORbio, Inc. before April 29, 2020:

Rigrodsky & Long is investigating potential claims against the board of directors of resTORbio, Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s agreement to merge with Adicet Bio, Inc.

Press Release

Rigrodsky & Long, P.A. announces that it is investigating resTORbio, Inc. (“resTORbio”) (NASDAQ GS: TORC) regarding possible breaches of fiduciary duties and other violations of law related to resTORbio’s agreement to merge with Adicet Bio, Inc. (“Adicet”). Under the terms of the agreement, resTORbio will issue a number of shares of resTORbio common stock to Adicet stockholders. Upon closing, shareholders of Adicet will own approximately 75% of the outstanding common stock of resTORbio, while resTORbio shareholders will own only approximately 25%.

If you would like to discuss this investigation and your rights cost and obligation free, please contact Seth D. Rigrodsky or Gina M. Serra toll free at (888) 969-4242 or by e-mail at

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Back to Page